Approval · Notice of Compliance 22182 · 2019
ENTYVIO: Notice of Compliance 22182
Issued May 6, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22182
- Date
- May 6, 2019
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of manufacturing and testing facilities
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ENTYVIO | Not yet assigned | — |
Medicinal ingredients
- VEDOLIZUMAB 331.2 MG per VIAL